Balanced news tone
News Sentiment
HYPD sentiment intelligence
Hyperion DeFi, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-11.3% over one week, -20.6% over four weeks, trend inactive, and below fair value.
What Does Hyperion DeFi's New Partnership with Silhouette Mean for HYPE Token Utility
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
What Does Hyperion DeFi's New Partnership with Silhouette Mean for HYPE Token Utility
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jul 2026 23:00
- Source
- Kavout | AI
Hyperion DeFi deploys 500,000 HYPE tokens under Skew agreement By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 21:44
- Source
- Investing.com Nigeria
Hyperion DeFi, Inc. (NASDAQ: HYPD) Share Price, HYPD Stock News, HYPD Share Price & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 20:00
- Source
- Kalkine
Hyperion DeFi (HYPD) Partners with Skew Technologies for Institu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 18:00
- Source
- GuruFocus
Hyperion DeFi จัดสรร 500,000 HYPE ภายใต้ข้อตกลง HAUS ร่วมกับ Skew Technologies เพื่อขยายตลาด Hyperliquid สำหรับนักลงทุนสถาบัน
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 17:10
- Source
- Moomoo
Hyperion DeFi Deploys 500,000 HYPE in HAUS Agreement with Skew Technologies to Expand Institutional Hyperliquid Markets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 17:10
- Source
- Quiver Quantitative
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
Hyperion DeFi Updates Executive Agreements and Compensation Structure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 13:38
- Source
- The Globe and Mail
Hyperion DeFi (HYPD) revises executive contracts with new bonuses and CIC pay
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 07:00
- Source
- Stock Titan
Enterprise value to revenue forward of Hyperion DeFi, Inc. – NASDAQ:HYPD
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 09:43
- Source
- TradingView
Hyperion DeFi (HYPD) grants 58,917 RSUs with 2027 and deal vesting triggers
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Hyperion DeFi teams with Blockdaemon to build institutional Hyperliquid staking
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Hyperion DeFi, Inc. Maintains 2026 Financial Guidance Despite Partnership Changes with Native Markets and Felix Markets | HYPD Stock News
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 08 Jun 2026 07:00
- Source
- Quiver Quantitative
Hyperion DeFi (NASDAQ: HYPD) to reallocate 800,000 HYPE tokens
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Stock Titan
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
HYPERION DEFI ($HYPD) Releases Q1 2026 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Quiver Quantitative
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Hyperion DeFi closes $10 million stock offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- Investing.com
Hyperion DeFi prices $10 million stock offering at $3.60/share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Investing.com
Hyperion DeFi seeks funds for more HYPE tokens via proposed sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
HYPD: Chardan Capital Initiates Coverage with 'Buy' Rating | HYPD Stock News
Chardan Capital has initiated coverage on Hyperion DeFi (HYPD) with a 'Buy' rating and a price target of $7.75 USD. This new coverage follows a previous 'Overweight' rating from Cantor Fitzgerald in December 2025. The average analyst target price for HYPD is $4.00, implying a 6.6
- Tone
- Positive 73/100
- Event
- Analyst action
- Published
- 24 Dec 2025 13:09
- Source
- GuruFocus
HYPD Stock Price and Chart — NASDAQ:HYPD
This article provides comprehensive information on Hyperion DeFi, Inc. (NASDAQ: HYPD), a clinical-stage biopharmaceutical company. It includes current stock price, financial metrics, employee data, company overview, recent news, analyst ratings, and frequently asked questions abo
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 29 Sep 2025 18:00
- Source
- TradingView
Hyperion DeFi (HYPD) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2025 04:56
- Source
- MarketBeat
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.
Eyenovia, Inc. has rebranded as Hyperion DeFi, Inc., reflecting its new strategic focus on a cryptocurrency treasury reserve strategy centered on the HYPE token. The company's shares are now trading under the new Nasdaq ticker symbol "HYPD" since July 3, 2025. This move aligns wi
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 08 Jul 2025 00:21
- Source
- VisionMonday